Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

Zelluna ASA Share Issue/Capital Change 2021

Oct 15, 2021

3779_rns_2021-10-15_b5587bc9-d6d1-4a71-becd-c6404183f5fa.html

Share Issue/Capital Change

Open in viewer

Opens in your device viewer

Ultimovacs ASA: New share capital registered

Ultimovacs ASA: New share capital registered

Oslo, 15 October 2021, Ultimovacs ASA (the "Company") refers to the announcement

published on 12 October 2021 regarding the issuance of new shares in connection

with the Company's employee incentive program.

The share capital increase related to the share issue has been registered in the

Norwegian Register of Business Enterprises, and the Company's new share capital

is NOK 3,206,176.10, divided into 32,061,761 shares, each with a par value of

NOK 0.10.

For further information, please contact:

Jónas Einarsson, Chairman of the Board of Directors of Ultimovacs ASA

Email: [email protected]

Phone: +47 480 96 355

Carlos de Sousa, CEO

Email: [email protected]

Phone: +47 908 92507

Hans Vassgård Eid, CFO

Email: [email protected]

Phone: +47 482 48632